The growth of the Stable Isotope Labeling Market is driven majorly by the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research and the rising prevalence of cancer.
According to research report Stable Isotope Labeling Market is projected to reach USD 312 million by 2024, grow at a CAGR of 3.0% during the forecast period.
The prominent players in the Stable Isotope Labeling Market include PerkinElmer Inc. (US), Merck KGaA (Germany), Omicron Biochemicals, Inc. (US), Trace Sciences International (US), URENCO Limited (UK), Cambridge Isotope Laboratories, Inc. (US), Medical Isotopes, Inc. (US), IsoSciences, LLC (US), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), and Rotem Industries Israel Ltd. (Israel).
Based on application, the stable isotope labeled compounds market is segmented into clinical diagnostics, research, industrial applications, and other applications. The research segment accounted for the largest share of the stable isotope-labeled compounds market in 2019, owing to rising research activities in the biomedical, environmental & ecological, pharmaceutical and agricultural sectors.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199